Investor profile
Bpifrance Large Venture has backed 9 European tech companies across 9 funding rounds between 2021 and 2024, joining rounds totalling €1.0B. Most active in Healthtech and Cleantech. Data as of 7 Aug 2026.
Also recorded as: Bpifrance Large Venture Fund
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Electra | France | 1 | €304M |
| Alma | France | 1 | €210M |
| 360Learning | France | 1 | €172M |
| DNA Script | France | 1 | €142M |
| TreeFrog Therapeutics | France |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Electra | Series B | €304M | 2024-01 |
| Alma | Series C | €210M | 2022-02 |
| 360Learning | Other | €172M | 2021-10 |
| DNA Script |
| 1 |
| €64M |
| Devialet | France | 1 | €49M |
| Calyxia | France | 1 | €32M |
| Foodles | France | 1 | €31M |
| Aqemia | France | 1 | €30M |
| €142M |
| 2021-10 |
| TreeFrog Therapeutics | Series B | €64M | 2021-09 |
| Devialet | Other | €49M | 2022-09 |
| Calyxia | Series B | €32M | 2024-09 |
| Foodles | Series B | €31M | 2021-09 |
| Aqemia | Series A | €30M | 2024-01 |
